Sildabol 100 - British Dragon

Sildenafil citrate, developed by Pfizer in 1989 and initially labeled UK-92,480, was originally intended as a treatment for angina. It acts by inhibiting PDE5, thereby maintaining elevated cGMP levels and promoting smooth muscle relaxation. While clinical trials showed limited success in cardiovascular use, researchers noted improved erectile function. This unexpected benefit led to its reclassification and approval as Viagra in 1998, revolutionizing ED treatment and making it the most widely prescribed drug of its kind globally.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Sildabol 100 by British Dragon, consult with your doctor or healthcare professional.